AlgoSource is a French company located on the Guérande Peninsula on the Atlantic coast and is a pioneer in the valorization of microalgae and salt marshes mother liquors extracts. For over thirty years, it has been identifying active molecules, extracting them using patented industrial processes with water and without chemicals, and packaging them into natural and bioactive food supplements. Its expertise is based on an R&D team that is among the most efficient in the world regarding active molecules from microorganisms. Its legitimacy has been built on an unprecedented track record of clinical trials within its ecosystem. After conducting the first double-blind, placebo-controlled human clinical trial with a spirulina extract concentrated in phycocyanin, AlgoSource is now the first microalgae company conducting a clinical trial in a hospital setting to demonstrate the efficacy of one of its extracts in reducing the side effects of chemotherapy. AlgoSource guarantees the quality of its products by carrying out all stages of its value chain in-house: it cultivates its own biomass, performs bio-extraction and sterilization of the active ingredients at its facilities, and packages its extracts into finished products at its factory. It is certified HACCP, ISO 9001, ISO 14001, Halal, and Sport Protect. The purpose of AlgoSource: offering the market bioactive, natural, innovative, and effective dietary supplements to improve the quality of life for consumers.